Correction to: Identifying Patients for Self-Administration of Omalizumab
Adv Ther
.
2023 Feb;40(2):719.
doi: 10.1007/s12325-022-02373-1.
Authors
Kevin R Murphy
1
,
Tonya Winders
2
3
,
Brandy Smith
4
,
Lauren Millette
4
,
Bradley E Chipps
5
Affiliations
1
Boys Town National Research Hospital, Boys Town, NE, USA.
2
Allergy and Asthma Network, Vienna, VA, USA.
3
Global Allergy and Airways Patient Platform, Vienna, Austria.
4
Genentech, Inc., South San Francisco, CA, USA.
5
Capital Allergy and Respiratory Disease Center, 5609 J Street, Suite C, Sacramento, CA, 95819, USA. bchipps@capitalallergy.com.
PMID:
36401056
PMCID:
PMC9898316
DOI:
10.1007/s12325-022-02373-1
No abstract available
Publication types
Published Erratum